Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India.
Publication/Presentation Date
3-1-2023
Abstract
Terlipressin is an analogue of vasopressin and is often used in the treatment of bleeding esophageal varices and also in the treatment of hepatorenal syndrome associated with liver cirrhosis. Although terlipressin is a safe drug, but it has been rarely associated with potentially serious adverse effects like ischemic necrosis of skin involving the abdominal skin, extremities, and scrotal skin. We present one such rare case where terlipressin-induced skin necrosis in bilateral lower extremities in a 48-year-old male while we were managing hepatorenal syndrome in the same.
Volume
15
Issue
3
First Page
36980
Last Page
36980
ISSN
2168-8184
Published In/Presented At
Sudan, S., Chaudhary, S., Bethineedi, L. D., Kaur, N., & Goyal, N. (2023). Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India. Cureus, 15(3), e36980. https://doi.org/10.7759/cureus.36980
Disciplines
Medicine and Health Sciences
PubMedID
37139269
Department(s)
Fellows and Residents
Document Type
Article